Cefpodoxime 200mg, Potassium Clavulanate 125mg 

In Critically Infectious conditions

INDICATED IN 

Nosocomial Infections

Skin & Soft Tissue Infections

Uncomplicated UTI

Acute Sinusitis

Urinary Tract Infections

Community-acquired 

Bronchopneumonia

CEFPODOXIME

Broad spectrum bactericidal antimicrobial

Ideal for switch over therapy from parenteral to oral

Shows greater tissue penetration that cefixime

POTASSIUM CLAVULANATE

Kills even ESBL producing pathogens

Excellent coverage against most Gram +ve & Gram -ve pathogens

Synergistic Combination against Pathogens